| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Case Report of Myoclonus-Dystonia with Isolated Myoclonus Phenotype and Novel Mutation Successfully Treated with Deep Brain Stimulation
|
Besa Lehmann, Valentina
|
|
|
|
1 |
p. 187-191
|
article
|
| 2 |
A Clinical Predictive Nomogram for Traumatic Brain Parenchyma Hematoma Progression
|
Sheng, Jiangtao
|
|
|
|
1 |
p. 185-203
|
article
|
| 3 |
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
|
Pardo, Gabriel
|
|
|
|
1 |
p. 337-351
|
article
|
| 4 |
A Markov Model Approach Assessing the Cost of Illness of Generalized Anxiety Disorder in Canada
|
Bereza, Basil G.
|
|
2012
|
|
1 |
p. 1-17
|
article
|
| 5 |
ANCA-Associated Vasculitic Neuropathies: A Review
|
Koike, Haruki
|
|
|
|
1 |
p. 21-38
|
article
|
| 6 |
An Integrative Nomogram for Identifying Cognitive Impairment Using Seizure Type and Cerebral Small Vessel Disease Neuroimaging Markers in Patients with Late-Onset Epilepsy of Unknown Origin
|
Wan, Huijuan
|
|
|
|
1 |
p. 107-125
|
article
|
| 7 |
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
|
Alroughani, Raed
|
|
2019
|
|
1 |
p. 13-23
|
article
|
| 8 |
A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia
|
Brown, David
|
|
2017
|
|
1 |
p. 129-139
|
article
|
| 9 |
A Principal Component Analysis Approach to Estimate the Disability Status for Patients with Multiple Sclerosis Using Japanese Claims Data
|
Kawachi, Izumi
|
|
|
|
1 |
p. 385-396
|
article
|
| 10 |
A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector
|
Farej, Ryan
|
|
|
|
1 |
p. 373-384
|
article
|
| 11 |
A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients
|
Bent-Ennakhil, Nawal
|
|
2017
|
|
1 |
p. 131-144
|
article
|
| 12 |
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
|
Allan, Michelle
|
|
|
|
1 |
p. 85-92
|
article
|
| 13 |
Association between Serum Amyloid A Level and White Matter Hyperintensity Burden: a Cross-Sectional Analysis in Patients with Acute Ischemic Stroke
|
Zhang, Peng
|
|
|
|
1 |
p. 161-175
|
article
|
| 14 |
Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke
|
Yang, Cui
|
|
|
|
1 |
p. 87-101
|
article
|
| 15 |
Association of Atrial Fibrillation with Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results from a Multicenter Study in China
|
Pan, Xiaoling
|
|
|
|
1 |
p. 127-139
|
article
|
| 16 |
ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs
|
Souza, Adriano Luís Soares De
|
|
2018
|
|
1 |
p. 103-128
|
article
|
| 17 |
Author’s Response to the Letter to the Editor Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives
|
Londos, Elisabet
|
|
2018
|
|
1 |
p. 165-167
|
article
|
| 18 |
A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study
|
Bove, Riley M.
|
|
2018
|
|
1 |
p. 135-145
|
article
|
| 19 |
Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions
|
Genis-Najera, Luis
|
|
|
|
1 |
p. 141-152
|
article
|
| 20 |
Brain Complexity Predicts Response to Adrenocorticotropic Hormone in Infantile Epileptic Spasms Syndrome: A Retrospective Study
|
Zhang, Chu-Ting
|
|
|
|
1 |
p. 129-144
|
article
|
| 21 |
Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
|
Matsumori, Yasuhiko
|
|
|
|
1 |
p. 205-222
|
article
|
| 22 |
Care Among Migraine Patients in a Commercially Insured Population
|
Bonafede, Machaon
|
|
|
|
1 |
p. 93-103
|
article
|
| 23 |
Caregiver Involvement in MS: Duty or Disruption?
|
Kesselring, Jürg
|
|
|
|
1 |
p. 9-20
|
article
|
| 24 |
Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
|
Chemer, Nataliia
|
|
2019
|
|
1 |
p. 25-27
|
article
|
| 25 |
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen
|
Coelho, Teresa
|
|
|
|
1 |
p. 267-287
|
article
|
| 26 |
Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis
|
Mori, Masayoshi
|
|
2013
|
|
1 |
p. 67-77
|
article
|
| 27 |
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
|
AlJumah, Mohamed
|
|
|
|
1 |
p. 11-23
|
article
|
| 28 |
Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study
|
Ramirez-García, Teresa
|
|
2016
|
|
1 |
p. 59-68
|
article
|
| 29 |
Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched Controls
|
Viscidi, Emma
|
|
|
|
1 |
p. 449-457
|
article
|
| 30 |
Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database
|
Boster, Aaron
|
|
2017
|
|
1 |
p. 91-102
|
article
|
| 31 |
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
|
Schwedt, Todd J.
|
|
|
|
1 |
p. 85-105
|
article
|
| 32 |
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review
|
Lakin, Lynsey
|
|
|
|
1 |
p. 75-98
|
article
|
| 33 |
Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case–Control Study
|
Fournier, Jean-Pascal
|
|
2015
|
|
1 |
p. 39-51
|
article
|
| 34 |
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
|
Rice, J. Bradford
|
|
|
|
1 |
p. 149-167
|
article
|
| 35 |
Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
|
Clavelou, Pierre
|
|
|
|
1 |
p. 255-256
|
article
|
| 36 |
Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
|
Urits, Ivan
|
|
|
|
1 |
p. 407
|
article
|
| 37 |
Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials
|
Ghezzi, Angelo
|
|
|
|
1 |
p. 193-195
|
article
|
| 38 |
Correction to: Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series
|
Dragusin, Andreea
|
|
|
|
1 |
p. 489
|
article
|
| 39 |
Correction to: Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
|
Dennis, Michael
|
|
2018
|
|
1 |
p. 169
|
article
|
| 40 |
Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
|
Makino, Koji
|
|
|
|
1 |
p. 117-133
|
article
|
| 41 |
Cost–Utility Analysis of Magnetic Resonance Imaging Management of Patients with Acute Ischemic Stroke in a Spanish Hospital
|
Parody, Elizabeth
|
|
2015
|
|
1 |
p. 25-37
|
article
|
| 42 |
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit
|
Merola, Aristide
|
|
|
|
1 |
p. 25-41
|
article
|
| 43 |
Deciphering the Network Effects of Deep Brain Stimulation in Parkinson's Disease
|
Gonzalez-Escamilla, Gabriel
|
|
|
|
1 |
p. 265-282
|
article
|
| 44 |
Depression Among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study
|
Ngum, Pleasure Atoh
|
|
2017
|
|
1 |
p. 103-114
|
article
|
| 45 |
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
|
Coelho, Teresa
|
|
|
|
1 |
p. 375-389
|
article
|
| 46 |
Design and Validation of a Clinical Outcome Measure for Adolescents and Adult Patients with Spinal Muscular Atrophy: SMA Life Study Protocol
|
Rebollo, Pablo
|
|
|
|
1 |
p. 233-249
|
article
|
| 47 |
Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study)
|
Madruga-Garrido, Marcos
|
|
|
|
1 |
p. 361-373
|
article
|
| 48 |
Development of a Population Pharmacokinetic Model for the Diroximel Fumarate Metabolites Monomethyl Fumarate and 2-Hydroxyethyl Succinimide Following Oral Administration of Diroximel Fumarate in Healthy Participants and Patients with Multiple Sclerosis
|
Kuchimanchi, Mita
|
|
|
|
1 |
p. 353-371
|
article
|
| 49 |
Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database
|
Chandler, Julie
|
|
|
|
1 |
p. 177-195
|
article
|
| 50 |
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment
|
Hauser, Robert A.
|
|
|
|
1 |
p. 459-469
|
article
|
| 51 |
Editorial Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives
|
Müller, Thomas
|
|
2018
|
|
1 |
p. 1-3
|
article
|
| 52 |
Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND
|
Repovic, Pavle
|
|
|
|
1 |
p. 169-182
|
article
|
| 53 |
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
|
Yang, Yang
|
|
|
|
1 |
p. 137-149
|
article
|
| 54 |
Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period
|
Ma, Jiuhong
|
|
|
|
1 |
p. 197-209
|
article
|
| 55 |
Effect of Tetrabenazine on Motor Function in Patients with Huntington Disease
|
Ferrara, Joseph M.
|
|
2012
|
|
1 |
p. 1-8
|
article
|
| 56 |
Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia
|
Mehta, Shyamal H.
|
|
|
|
1 |
p. 307-320
|
article
|
| 57 |
Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study
|
Lorefice, Lorena
|
|
|
|
1 |
p. 39-49
|
article
|
| 58 |
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
|
Belmokhtar, Chafké
|
|
2019
|
|
1 |
p. 69-78
|
article
|
| 59 |
Emerging Immunotherapies for Parkinson Disease
|
Zella, Samis M. A.
|
|
2018
|
|
1 |
p. 29-44
|
article
|
| 60 |
Endovascular Treatment in Acute Ischemic Stroke with Large Vessel Occlusion According to Different Stroke Subtypes: Data from ANGEL-ACT Registry
|
Huo, Xiaochuan
|
|
|
|
1 |
p. 151-165
|
article
|
| 61 |
Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study
|
Gendolla, Astrid
|
|
|
|
1 |
p. 167-183
|
article
|
| 62 |
Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine
|
Autio, Henri
|
|
|
|
1 |
p. 223-235
|
article
|
| 63 |
Evaluating Elements of the Care Partner Experience in Individuals Who Care for People with Alzheimer's Disease Across the Severity Spectrum
|
Callahan, Leigh F.
|
|
|
|
1 |
p. 53-67
|
article
|
| 64 |
Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
|
Knapp, Rachel K.
|
|
|
|
1 |
p. 247-263
|
article
|
| 65 |
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years
|
Merlini, Giampaolo
|
|
|
|
1 |
p. 105-115
|
article
|
| 66 |
Evidence-Based Recommendations for the Oral Health of Patients with Parkinson’s Disease
|
Martimbianco, Ana L. C.
|
|
|
|
1 |
p. 391-400
|
article
|
| 67 |
Exercise in Multiple Sclerosis: Knowing is Not Enough—The Crucial Role of Intention Formation and Intention Realization
|
Schüler, Julia
|
|
2019
|
|
1 |
p. 5-11
|
article
|
| 68 |
Functional Near-Infrared Spectroscopy as a Target Navigator for rTMS Modulation in Patients with Hemiplegia: A Randomized Control Study
|
Chang, Pang-Wei
|
|
|
|
1 |
p. 103-121
|
article
|
| 69 |
Galcanezumab Effects on Migraine Severity and Symptoms in Japanese Patients with Episodic Migraine: Secondary Analysis of a Phase 2 Randomized Trial
|
Igarashi, Hisaka
|
|
|
|
1 |
p. 73-87
|
article
|
| 70 |
Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
|
Héraud, Charlotte
|
|
|
|
1 |
p. 499-505
|
article
|
| 71 |
Global Peginterferon Beta-1a Tolerability Management Best Practices: A Nurse-Focused Delphi Approach
|
White, Sarah
|
|
|
|
1 |
p. 251-263
|
article
|
| 72 |
Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary
|
Au, Ka Loong Kelvin
|
|
|
|
1 |
p. 7-30
|
article
|
| 73 |
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
|
Aram, Jehan
|
|
2018
|
|
1 |
p. 45-57
|
article
|
| 74 |
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
|
Malucchi, Simona
|
|
2016
|
|
1 |
p. 145-152
|
article
|
| 75 |
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
|
Andrews, Megan
|
|
2018
|
|
1 |
p. 51-58
|
article
|
| 76 |
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study
|
Millán-Pascual, Jorge
|
|
|
|
1 |
p. 153-164
|
article
|
| 77 |
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
|
AlSharoqi, Isa Ahmed
|
|
|
|
1 |
p. 55-66
|
article
|
| 78 |
Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study
|
Awaki, Etsuko
|
|
|
|
1 |
p. 165-182
|
article
|
| 79 |
Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy
|
González‐Duarte, Alejandra
|
|
|
|
1 |
p. 135-149
|
article
|
| 80 |
Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed
|
Lacey, Loretto
|
|
2016
|
|
1 |
p. 11-23
|
article
|
| 81 |
Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative Review
|
Stoll, Sharon
|
|
|
|
1 |
p. 21-37
|
article
|
| 82 |
Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case Report
|
Al-Jehani, Hosam
|
|
2019
|
|
1 |
p. 161-165
|
article
|
| 83 |
Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis
|
Vermersch, Patrick
|
|
|
|
1 |
p. 1-10
|
article
|
| 84 |
Laquinimod Therapy in Multiple Sclerosis: A Comprehensive Review
|
Kolb-Sobieraj, Channa
|
|
2014
|
|
1 |
p. 29-39
|
article
|
| 85 |
Latent Class Analysis to Classify Patients with Transthyretin Amyloidosis by Signs and Symptoms
|
Alvir, Jose
|
|
2015
|
|
1 |
p. 11-24
|
article
|
| 86 |
Lennox–Gastaut Syndrome: Perspective of a Parent and a Physician
|
McKee, Heather R.
|
|
|
|
1 |
p. 1-5
|
article
|
| 87 |
Letter to the Editor Regarding Fleischer et al. Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic
|
Vink, Mark
|
|
|
|
1 |
p. 329-332
|
article
|
| 88 |
Letter to the Editor Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives
|
Brzezicki, Maksymilian Aleksander
|
|
2018
|
|
1 |
p. 161-163
|
article
|
| 89 |
Letter to the Editor Regarding “Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL Study”
|
Braid, Jessica
|
|
|
|
1 |
p. 251-254
|
article
|
| 90 |
Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study
|
Patel, Preeya J.
|
|
|
|
1 |
p. 121-147
|
article
|
| 91 |
Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series
|
Dragusin, Andreea
|
|
|
|
1 |
p. 481-487
|
article
|
| 92 |
Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
|
Capet, Nicolas
|
|
|
|
1 |
p. 507-513
|
article
|
| 93 |
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis
|
Coelho, Teresa
|
|
2016
|
|
1 |
p. 1-25
|
article
|
| 94 |
Medication Therapy Management Service for Patients with Parkinson’s Disease: A Before-and-After Study
|
Foppa, Aline Aparecida
|
|
2016
|
|
1 |
p. 85-99
|
article
|
| 95 |
Mexazolam: Clinical Efficacy and Tolerability in the Treatment of Anxiety
|
Fernandes, Hélder
|
|
2014
|
|
1 |
p. 1-14
|
article
|
| 96 |
Migraine and Ischemic Stroke: A Mendelian Randomization Study
|
Shu, Mei-Jun
|
|
|
|
1 |
p. 237-246
|
article
|
| 97 |
MIND Diet Adherence Might be Associated with a Reduced Odds of Multiple Sclerosis: Results from a Case–Control Study
|
Noormohammadi, Morvarid
|
|
|
|
1 |
p. 397-412
|
article
|
| 98 |
Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series
|
Avila, Mirla
|
|
|
|
1 |
p. 319-327
|
article
|
| 99 |
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies
|
Iyer, Priyanka
|
|
|
|
1 |
p. 1-10
|
article
|
| 100 |
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
|
Liseno, Jacob
|
|
|
|
1 |
p. 349-360
|
article
|
| 101 |
Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial Subanalysis
|
Saida, Takahiko
|
|
2017
|
|
1 |
p. 153-159
|
article
|
| 102 |
Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
|
Wingerchuk, Dean M.
|
|
|
|
1 |
p. 123-135
|
article
|
| 103 |
Neurology and Therapy: Looking Back on 2018 and Forward to 2019
|
Sabbagh, Marwan
|
|
2019
|
|
1 |
p. 1-3
|
article
|
| 104 |
Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada
|
Nevin, Remington L.
|
|
2016
|
|
1 |
p. 69-83
|
article
|
| 105 |
No Changes in Functional Connectivity After Dimethyl Fumarate Treatment in Multiple Sclerosis
|
Piervincenzi, Claudia
|
|
|
|
1 |
p. 471-479
|
article
|
| 106 |
Non-drug Therapies for Alzheimer’s Disease: A Review
|
Li, Xianqian
|
|
|
|
1 |
p. 39-72
|
article
|
| 107 |
Number Needed to Treat in Multiple Sclerosis Clinical Trials
|
Okwuokenye, Macaulay
|
|
2017
|
|
1 |
p. 1-9
|
article
|
| 108 |
On Gelsemium and Complementary and Alternative Medicine (CAM) in Anxiety and Experimental Neurology
|
Chirumbolo, Salvatore
|
|
2014
|
|
1 |
p. 1-10
|
article
|
| 109 |
Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative Assessment
|
Porter, Katherine Ackerman
|
|
|
|
1 |
p. 197-212
|
article
|
| 110 |
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
|
Mamelak, Mortimer
|
|
2018
|
|
1 |
p. 5-11
|
article
|
| 111 |
Paroxysmal Sympathetic Hyperactivity After Acquired Brain Injury: An Integrative Review of Diagnostic and Management Challenges
|
Xu, Sui-yi
|
|
|
|
1 |
p. 11-20
|
article
|
| 112 |
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
|
Kritikos, Minos
|
|
|
|
1 |
p. 159-171
|
article
|
| 113 |
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review
|
Davis, Bryan E.
|
|
|
|
1 |
p. 99-119
|
article
|
| 114 |
PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit
|
Lang, Michael
|
|
2019
|
|
1 |
p. 147-154
|
article
|
| 115 |
Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy
|
Motuzova, Yana
|
|
2015
|
|
1 |
p. 53-60
|
article
|
| 116 |
Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory Medicine
|
Kantor, Daniel
|
|
2017
|
|
1 |
p. 37-49
|
article
|
| 117 |
Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Patient Education
|
Kantor, Daniel
|
|
2017
|
|
1 |
p. 23-36
|
article
|
| 118 |
Pharmacokinetics, Pharmacodynamics, and Tolerability of Opicapone in Healthy Chinese and Caucasian Subjects: An Open-Label, Single-Center, Phase 1 Study
|
Cong, Duanduan
|
|
|
|
1 |
p. 283-301
|
article
|
| 119 |
Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
|
Avolio, Carlo
|
|
|
|
1 |
p. 1-8
|
article
|
| 120 |
Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States
|
Parawira, Sandra
|
|
|
|
1 |
p. 1-9
|
article
|
| 121 |
Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms
|
Keine, Dorothy
|
|
2019
|
|
1 |
p. 79-94
|
article
|
| 122 |
Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
|
Mundayat, Rajiv
|
|
2018
|
|
1 |
p. 87-101
|
article
|
| 123 |
Potentially Inappropriate Medications in a Psychogeriatric Inpatient Ward: An Audit Based on Beers Criteria
|
Moebs, Isabelle
|
|
|
|
1 |
p. 151-157
|
article
|
| 124 |
Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review
|
Baumel, Barry S.
|
|
|
|
1 |
p. 43-60
|
article
|
| 125 |
Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives
|
Londos, Elisabet
|
|
2017
|
|
1 |
p. 13-22
|
article
|
| 126 |
Prescription Patterns of Medications for Alzheimer’s Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study
|
Kadohara, Kimiko
|
|
2016
|
|
1 |
p. 25-37
|
article
|
| 127 |
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries
|
Antonini, Angelo
|
|
|
|
1 |
p. 303-318
|
article
|
| 128 |
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective
|
Meca-Lallana, José
|
|
|
|
1 |
p. 173-179
|
article
|
| 129 |
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
|
Devine, Jaime K.
|
|
|
|
1 |
p. 249-265
|
article
|
| 130 |
Quantifying Knowledge of Alzheimer’s Disease: An Analysis of the Psychometric Properties of the Alzheimer’s Disease Knowledge Scale
|
Garcia-Ribas, Guillermo
|
|
|
|
1 |
p. 213-224
|
article
|
| 131 |
Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients
|
Lee, Andrew
|
|
2017
|
|
1 |
p. 79-90
|
article
|
| 132 |
Rapid Rescue Treatment with Diazepam Nasal Spray Leads to Faster Seizure Cluster Termination in Epilepsy: An Exploratory Post Hoc Cohort Analysis
|
Misra, Sunita N.
|
|
|
|
1 |
p. 221-231
|
article
|
| 133 |
Rasagiline and Rapid Symptomatic Motor Effect in Parkinson’s Disease: Review of Literature
|
Pistacchi, Michele
|
|
2013
|
|
1 |
p. 41-66
|
article
|
| 134 |
Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis
|
Claassen, Daniel O.
|
|
|
|
1 |
p. 435-448
|
article
|
| 135 |
Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
|
Lager, Brittney
|
|
|
|
1 |
p. 145-159
|
article
|
| 136 |
Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes
|
Min, Jinny
|
|
2019
|
|
1 |
p. 109-119
|
article
|
| 137 |
Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany
|
Müller, Sabrina
|
|
|
|
1 |
p. 67-83
|
article
|
| 138 |
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers
|
Faust, Elizabeth
|
|
|
|
1 |
p. 293-306
|
article
|
| 139 |
Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE
|
Lipton, Richard B.
|
|
|
|
1 |
p. 69-83
|
article
|
| 140 |
Recognition and Practice of Hypopituitarism After Traumatic Brain Injury and Subarachnoid Hemorrhage in Japan: A Survey
|
Tahara, Shigeyuki
|
|
|
|
1 |
p. 39-51
|
article
|
| 141 |
Recognition of Facial Emotion Expressions in Patients with Depressive Disorders: A Prospective, Observational Study
|
Akhapkin, Roman Vitalievich
|
|
|
|
1 |
p. 225-234
|
article
|
| 142 |
Response Letter to Vink et al. ‘Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic’
|
Stettner, Mark
|
|
|
|
1 |
p. 333-336
|
article
|
| 143 |
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®) for Pseudobulbar Affect
|
Pioro, Erik P.
|
|
2014
|
|
1 |
p. 15-28
|
article
|
| 144 |
Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study
|
Guo, Rong-Jing
|
|
|
|
1 |
p. 73-86
|
article
|
| 145 |
Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
|
Dennis, Michael
|
|
2017
|
|
1 |
p. 57-77
|
article
|
| 146 |
Risperdal® CONSTA® Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans Affairs
|
Wilcox, Marsha A.
|
|
2019
|
|
1 |
p. 95-108
|
article
|
| 147 |
Rivaroxaban in Recurrent Ischemic Stroke Due to Protein S Deficiency: A Case Report
|
Naghavi, Saba
|
|
|
|
1 |
p. 401-406
|
article
|
| 148 |
Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial
|
Saida, Takahiko
|
|
2016
|
|
1 |
p. 39-55
|
article
|
| 149 |
SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological Disorders
|
Losy, Jacek
|
|
|
|
1 |
p. 31-42
|
article
|
| 150 |
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial
|
Bar-Or, Amit
|
|
|
|
1 |
p. 303-317
|
article
|
| 151 |
Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
|
Bahadorizadeh, Leyla
|
|
|
|
1 |
p. 491-497
|
article
|
| 152 |
Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis
|
Ruetsch-Chelli, Caroline
|
|
|
|
1 |
p. 289-302
|
article
|
| 153 |
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
|
Tahami Monfared, Amir Abbas
|
|
|
|
1 |
p. 413-434
|
article
|
| 154 |
STO: Stroke Ontology for Accelerating Translational Stroke Research
|
Habibi-koolaee, Mahdi
|
|
|
|
1 |
p. 321-333
|
article
|
| 155 |
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
|
Gold, Ralf
|
|
2016
|
|
1 |
p. 45-57
|
article
|
| 156 |
Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin
|
Demas, Alexis
|
|
|
|
1 |
p. 181-185
|
article
|
| 157 |
Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson’s Disease
|
Lekomtseva, Yevgeniya
|
|
2019
|
|
1 |
p. 59-68
|
article
|
| 158 |
Targeting of the Subthalamic Nucleus in Patients with Parkinson’s Disease Undergoing Deep Brain Stimulation Surgery
|
van den Munckhof, Pepijn
|
|
|
|
1 |
p. 61-73
|
article
|
| 159 |
The Association Between Dietary Acid Load and Odds of Migraine: A Case–Control Survey
|
Mousavi, Maryam
|
|
|
|
1 |
p. 335-348
|
article
|
| 160 |
The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy
|
Muntoni, Francesco
|
|
|
|
1 |
p. 183-219
|
article
|
| 161 |
The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the Neutral
|
Morris-Bankole, Hannah
|
|
|
|
1 |
p. 279-291
|
article
|
| 162 |
The Early Diagnosis of Alzheimer’s Disease: A Patient-Centred Conversation with the Care Team
|
Nasreddine, Ziad
|
|
|
|
1 |
p. 11-23
|
article
|
| 163 |
The Human Body’s Own Language to be Considered for Safe and Effective Neurostimulation
|
Tulgar, Metin
|
|
2012
|
|
1 |
p. 1-7
|
article
|
| 164 |
The Impact of Red Blood Cell Distribution Width and Neutrophil/Lymphocyte Ratio on the Diagnosis of Major Depressive Disorder
|
Demircan, Fatih
|
|
2015
|
|
1 |
p. 27-33
|
article
|
| 165 |
The Impact of Spina Bifida on Caregivers
|
Rofail, Diana
|
|
2012
|
|
1 |
p. 1-12
|
article
|
| 166 |
The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers
|
Respondek, Gesine
|
|
|
|
1 |
p. 229-247
|
article
|
| 167 |
The Misdiagnosis of CIDP: A Review
|
Allen, Jeffrey A.
|
|
|
|
1 |
p. 43-54
|
article
|
| 168 |
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
|
Frahm, Niklas
|
|
|
|
1 |
p. 319-336
|
article
|
| 169 |
The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: Efficacy and Clinical Implications
|
Bernardo, Pia
|
|
2019
|
|
1 |
p. 155-160
|
article
|
| 170 |
Treatment of Adults with Lennox–Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide
|
McMurray, Rob
|
|
2016
|
|
1 |
p. 35-43
|
article
|
| 171 |
Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
|
Sikirica, Vanja
|
|
2017
|
|
1 |
p. 115-130
|
article
|
| 172 |
Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment
|
Sanchirico, Marie
|
|
2018
|
|
1 |
p. 121-133
|
article
|
| 173 |
Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors
|
Dranitsaris, George
|
|
|
|
1 |
p. 211-227
|
article
|
| 174 |
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
|
Tatsuoka, Yoshihisa
|
|
|
|
1 |
p. 265-278
|
article
|
| 175 |
Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series
|
Lester, Jacobo
|
|
2018
|
|
1 |
p. 155-159
|
article
|
| 176 |
Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers
|
Habek, Mario
|
|
|
|
1 |
p. 25-37
|
article
|
| 177 |
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
|
Hutchinson, Susan
|
|
|
|
1 |
p. 235-249
|
article
|
| 178 |
Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for Integrative Data Analytic Approaches
|
Serrano, Daniel
|
|
2018
|
|
1 |
p. 141-154
|
article
|
| 179 |
Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient’s Perspective: A Qualitative Study
|
Jackson, Kristi
|
|
|
|
1 |
p. 107-128
|
article
|
| 180 |
Use of a Novel EEG-Based Objective Test, the Cognalyzer®, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework
|
Bosnyak, Dan
|
|
|
|
1 |
p. 51-72
|
article
|
| 181 |
Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL Study
|
Vázquez-Costa, Juan F.
|
|
|
|
1 |
p. 89-105
|
article
|
| 182 |
Virtual Reality Versus Conventional Treatment of Reaching Ability in Chronic Stroke: Clinical Feasibility Study
|
Levin, Mindy F.
|
|
2012
|
|
1 |
p. 1-15
|
article
|
| 183 |
Vitamin D and Multiple Sclerosis: A Comprehensive Review
|
Sintzel, Martina B.
|
|
2017
|
|
1 |
p. 59-85
|
article
|
| 184 |
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis
|
Neuberger, Edward E.
|
|
|
|
1 |
p. 183-196
|
article
|
Journal description